{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-006402","form_type":"8-K","ticker":"SIGY","cik":"0001642159","company_name":"Sigyn Therapeutics, Inc.","filed_at":"2022-03-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.526020+00:00","generated_at":"2026-06-27T00:25:05.205357+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Sigyn Therapeutics appoints Jeremy Ferrell as CFO, effective March 9, 2022","bullets":["Jeremy Ferrell (CPA, MBA) appointed CFO; base salary $250,000/year, annual bonus up to 40%.","Stock options for up to 600,000 shares at grant date market price; 25% vest at grant, rest over 3 years.","Employment agreement is indefinite duration, at-will; includes standard terms.","Ferrell has 25+ years finance experience; most recently CFO at Miku, Inc."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-006402","json":"https://secwatch.observer/filing/0001493152-22-006402.json","markdown":"https://secwatch.observer/filing/0001493152-22-006402.md","text":"https://secwatch.observer/filing/0001493152-22-006402.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642159/000149315222006402/0001493152-22-006402-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642159/000149315222006402/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T00:25:05.205357+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"29ca453b41","claim":"Jeremy Ferrell was appointed as Chief Financial Officer at Sigyn Therapeutics, Inc..","evidence_excerpt":"The Board of Directors of Sigyn Therapeutics, Inc. (“the Company”) appointed Jeremy Ferrell, CPA, MBA as Chief Financial Officer (“CFO”), effective March 9, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642159/000149315222006402/0001493152-22-006402-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}